BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 28133282)

  • 21. [Metastatic breast cancer with microangiopathic hemolytic anemia successfully treated by using eribulin].
    Morita M; Fukuda K; Konishi T; Kiuchi J; Umehara S; Nakashima S; Fujiyama J; Masuyama M
    Gan To Kagaku Ryoho; 2014 Sep; 41(9):1139-41. PubMed ID: 25248898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
    Reitsamer R; Peintinger F; Rettenbacher L; Prokop E
    J Surg Oncol; 2003 Oct; 84(2):63-7. PubMed ID: 14502778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Experience with eribulin in the treatment of elderly women with metastatic breast cancer: case studies.
    Garrido ML; Morago AJ; Rovira PS; Olarte PE; Sánchez CP; Sánchez LM
    Future Oncol; 2018 Mar; 14(7s):21-27. PubMed ID: 29611758
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathological features and prognostic factors of breast cancer patients with inguinal lymph node metastases: a report of 17 cases].
    Li Q; Xu BH; Zhang P; Li Q; Yuan P; Wang JY; Luo Y; Ma F; Fan Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):207-11. PubMed ID: 23880002
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A case of non-palpating breast cancer with huge lymph node metastasis].
    Hara Y; Sakurai K; Fujisaki S; Nagashima S; Suzuki S; Shibata M; Tomita R; Matsumoto K; Enomoto K; Amano S
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2014-6. PubMed ID: 22202269
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Maintenance of Long-Term Stable Disease(SD)in Metastatic Breast Cancer with Eribulin - A Case Report of Long-Term SD in Japan].
    Nitta T; Kimura K; Tominaga T; Fujii K; Sato N; Ikari A; Miyoshi K; Tanaka S; Ishibashi T; Iwamoto M
    Gan To Kagaku Ryoho; 2016 Dec; 43(13):2543-2546. PubMed ID: 28028262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary sentinel lymph node biopsy after neoadjuvant chemotherapy for carcinoma of the breast.
    Schwartz GF; Tannebaum JE; Jernigan AM; Palazzo JP
    Cancer; 2010 Mar; 116(5):1243-51. PubMed ID: 20087958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].
    Ma WY; Zhang P; Zhang BL; Wang X; Xu XZ; Zheng S; Wang JY; Cai RG; Yuan P; Ma F; Fan Y; Xu BH
    Zhonghua Zhong Liu Za Zhi; 2012 Oct; 34(10):770-4. PubMed ID: 23291072
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.
    Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN
    Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
    Gatek J; Vrana D; Hnatek L; Bakala J; Dudesek B; Duben J; Musil T
    J BUON; 2012; 17(2):265-70. PubMed ID: 22740204
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Efficacy and safety of eribulin for metastatic breast cancer patients].
    Okishiro M; Egawa C; Kusama H; Matsushita K; Hashimoto N; Kawashima H; Mukai Y; Hamanaka M; Takeno A; Sakisaka H; Nakahira S; Taniguchi H; Suzuki R; Takeda Y; Kato T; Tamura S; Takatsuka Y
    Gan To Kagaku Ryoho; 2014 Feb; 41(2):215-9. PubMed ID: 24743200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A long-term response to eribulin].
    Patient M; Tsogou PTN; Roméo E; Bladé JS; de Jauréguiberry JP; Boudin L
    Bull Cancer; 2018; 105(7-8):636-638. PubMed ID: 29910045
    [No Abstract]   [Full Text] [Related]  

  • 33. Feasibility and accuracy of sentinel lymph node biopsy after preoperative chemotherapy in breast cancer patients with documented axillary metastases.
    Shen J; Gilcrease MZ; Babiera GV; Ross MI; Meric-Bernstam F; Feig BW; Kuerer HM; Francis A; Ames FC; Hunt KK
    Cancer; 2007 Apr; 109(7):1255-63. PubMed ID: 17330229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective surgical localization of axillary lymph nodes containing metastases in patients with breast cancer: a prospective feasibility trial.
    Caudle AS; Yang WT; Mittendorf EA; Black DM; Hwang R; Hobbs B; Hunt KK; Krishnamurthy S; Kuerer HM
    JAMA Surg; 2015 Feb; 150(2):137-43. PubMed ID: 25517573
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy.
    Kuerer HM; Newman LA; Smith TL; Ames FC; Hunt KK; Dhingra K; Theriault RL; Singh G; Binkley SM; Sneige N; Buchholz TA; Ross MI; McNeese MD; Buzdar AU; Hortobagyi GN; Singletary SE
    J Clin Oncol; 1999 Feb; 17(2):460-9. PubMed ID: 10080586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer.
    Kashiwagi S; Asano Y; Goto W; Takada K; Takahashi K; Noda S; Takashima T; Onoda N; Tomita S; Ohsawa M; Hirakawa K; Ohira M
    PLoS One; 2017; 12(2):e0170634. PubMed ID: 28166544
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [A case regarded as an occult breast cancer treated without mastectomy].
    Kawashima T; Miyazawa Y; Sakata H; Matsubara H; Ryu M; Ochiai T
    Gan To Kagaku Ryoho; 2005 Jun; 32(6):825-8. PubMed ID: 15984524
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comprehensive axillary evaluation in neoadjuvant chemotherapy patients with ultrasonography and sentinel lymph node biopsy.
    Khan A; Sabel MS; Nees A; Diehl KM; Cimmino VM; Kleer CG; Schott AF; Hayes DF; Chang AE; Newman LA
    Ann Surg Oncol; 2005 Sep; 12(9):697-704. PubMed ID: 16079956
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A Case of Recurrent Breast Cancer with Complete Response to Eribulin Monotherapy after Bevacizumab plus Paclitaxel Combination Therapy].
    Higashi T; Ozawa K; Takagi S; Onodera Y; Yokoyama M; Mase K; Moriya T; Takeshita A; Mizutani M; Usuba O
    Gan To Kagaku Ryoho; 2018 Jul; 45(7):1093-1095. PubMed ID: 30042279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experience with eribulin in triple-negative metastatic breast cancer: case studies.
    Gallegos Sancho MI; Márquez-Vázquez R; Sánchez-Muñoz A
    Future Oncol; 2018 Mar; 14(7s):13-20. PubMed ID: 29611754
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.